Authors

Norah Alsumih, King Saud bin Abdulaziz University for Health Sciences, Saudi ArabiaFollow
Rahaf Alqahtani, King Saud bin Abdulaziz University for Health Sciences, Saudi ArabiaFollow
Faisal Almutairi, King Saud bin Abdulaziz University for Health Sciences, Saudi ArabiaFollow
Rakan Faraj, UMM AlQura University, Saudi ArabiaFollow
Turki Alsubeai, Taif University, Saudi ArabiaFollow
Ahmed Alghanim, Arabian Gulf University, BahrainFollow
Shmylan Alharbi, King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia
Hind Almodaimegh, King Saud bin Abdulaziz University for Health Sciences, Saudi ArabiaFollow

The Use of Antidepressants in Patients with Heart Failure

Abstract

Background: Heart failure (HF) is a chronic disease affecting patients’ quality of life (QoL) and may cause depression. Recent studies reported that the prevalence of depression in patients with HF is 21.5%. Antidepressants, mainly selective serotonin reuptake inhibitors, are usually prescribed for HF patients diagnosed with depression. Some evidence supports antidepressant’s role in improving symptoms by enhancing the psychological aspect of their QoL. Depression screening and treatment are important in the multidisciplinary management; however, their survival benefits are inconsistent. In our study, we aim to investigate the prevalence of depression and the use of antidepressants in patients with HF as well as to determine the acceptance of using antidepressants in such patients. Methods: This is a cross-sectional study conducted by interviewing HF outpatients at National Guard Hospital in Riyadh. Patients were assessed using Hamilton depression rating scale. Results: A total of 306 patients were included, with the majority (69%) being male and aged >61 years (60%). Patients’ medical history was classified into different groups, with the largest proportion (39.9%) in the diabetic-hypertensive group, followed by a diabetic group (21.2%) and a hypertensive group (10.8%). Patients were classified according to the New York Heart Association Functional Classification, and most patients were in Class I (61.8%). Some of the patients (8.5%) had been diagnosed with depression. There was no statistically significant association between HF and depression ( p > 0.05). However, 5.6% of patients had been prescribed antidepressants and 17.1% of patients believed that they required antidepressants. Moreover, there was a statically significant association between medical history and development of depression ( p¼0.014). Conclusions: The prevalence of depression in HF patients in our population was lower than reported. There was no association between HF stage, depression, and antidepressant use.

Recommended Citation

Alsumih, Norah; Alqahtani, Rahaf; Almutairi, Faisal; Faraj, Rakan; Alsubeai, Turki; Alghanim, Ahmed; Alharbi, Shmylan; and Almodaimegh, Hind (2020) "The Use of Antidepressants in Patients with Heart Failure," Journal of the Saudi Heart Association: Vol. 32 : Iss. 1 , Article 9.
Available at: https://doi.org/10.37616/2212-5043.1008

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.